Ophthalmic Devices
RetinAI launches Discovery platform to enhance ophthalmic care
RetinAI, a provider of software solutions for image processing and artificial intelligence (AI) in ophthalmology, has introduced the RetinAI Discovery…
LumiThera requests FDA for de novo reclassification of ocular device
US-based LumiThera has submitted a de novo request to reclassify the Valeda light delivery system as a Class II device,…
iSTAR Medical introduces glaucoma treatment device in Netherlands
iSTAR Medical has introduced its MINIject device for the treatment of patients with glaucoma, in the Netherlands. The latest development…
AXIM and Auer partner for dry eye disease assay production
AXIM Biotechnologies has signed an agreement with Auer Precision to scale up the production of its two diagnostic assays for…
Sight Sciences touts positive six-month results for heat therapy device
Sight Sciences has revealed further positive results from its SAHARA trial investigating TearCare technology for the treatment of dry eye…
Zeiss acquires Dutch Ophthalmic Research Center in $1bn deal
Carl Zeiss Meditec has entered an agreement to acquire Dutch Ophthalmic Research Center to expand its ophthalmic device portfolio. As…
Belkin Vision’s glaucoma laser receives 510(k) clearance from FDA
Israeli medical device company Belkin Vision has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its…
Pantheon Vision launches with $2.5m to develop bioengineered corneal implants
Pantheon Vision has launched with $2.5m in seed funding to develop bioengineered corneal implants to treat corneal blindness. The US-based…
Phase I/II trial begins for SpyGlass intraocular drug delivery implant
SpyGlass Pharma is initiating Phase I/II clinical trials investigating its drug delivery platform in patients with glaucoma and visually significant…
Patient enrolment completes in ViaLase Laser pivotal trial
ViaLase has concluded the enrolment of adult patients in the VIA-002 pivotal trial for the treatment of primary open-angle glaucoma…